Drug intelligence / Profile preview

ReColorCell

Development stage
Unknown
Lead developer
Cell Tech Pharmed
Modality
Cell Therapies
Administration
Intradermal
01

Overview

ReColorCell is an autologous cell therapy consisting of a suspension of non-cultured melanocytes and keratinocytes. Developed by the Royan Institute and Cell Tech Pharmed, it is designed for the treatment of vitiligo, an autoimmune skin disorder characterized by depigmented patches. The therapy involves harvesting a skin biopsy from the patient, isolating the melanocytes and keratinocytes, and transplanting them back into the patient's depigmented epidermal areas to restore melanin production and skin pigmentation. ReColorCell was approved by the Iranian Food and Drug Administration (IR-FDA) and registered in the Iranian Drug List in December 2021.

Brand names
ReColorCell
Other names
Recolorcellautologous melanocyte-keratinocyte suspensionautologous melanocyte-keratinocyte transplantationautologous melanocytes and keratinocytes

Beyond the preview

Go deeper on ReColorCell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ReColorCell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call